2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

2020/07/10 by Jean‐Philippe Collet, Hölger Thiele, ESC Scientific Document Group +67 · 20 citations
Medicine · #Acute Myocardial Infarction Research #Cardiac Imaging and Diagnostics #Coronary Interventions and Diagnostics

paper · pdf · doi:10.1093/eurheartj/ehaa575

openalex publication_date 2020/07/10 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Abstract

A correction has been published: European Heart Journal, ehaa895, https://doi.org/10.1093/eurheartj/ehaa895

Citations

• Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events
• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
• Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study

Cited by

• 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
• 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
• 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
• A diagnostic model for non-invasive localization of culprit lesions in NSTE-ACS by integrating CCTA geometric and plaque parameters
• Improving Care with the First measurement of high-sensitivity troponin T (ICare-FirsT) to enable early rule out and reduce length of stay: a diagnostic and observational study
• The Role of Inflammation in Cardiovascular Disease
• 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
• Evidence-based medicine and the cardiac troponin 99th percentile for the diagnosis of acute myocardial infarction
• Comparison of Efficacy of Atorvastatin and Rosuvastatin in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
• 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
• Multimorbidity in Acute Coronary Syndrome
• National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025
• Adverse outcomes after surgery after a cerebrovascular accident or acute coronary syndrome: a retrospective observational cohort study
• Organized thrombus is a frequent underlying feature in culprit lesion morphology in non-ST-elevation myocardial infarction. A study using optical coherence tomography and magnetic resonance imaging
• 2021 ESC/EACTS Guidelines for the management of valvular heart disease
• Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry
• Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients
• P2Y12 inhibition in acute coronary syndromes treated with percutaneous intervention – Understanding the debate on Prasugrel or Ticagrelor
• 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
• Cardiac involvement in polymyositis and dermatomyositis: diagnostic approaches.

Related

• 2023 ESC Guidelines for the management of acute coronary syndromes
• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
• Diagnosis and Treatment of Acute Coronary Syndromes
• 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
• 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure